Fund shareholders of Altimmune Inc
ISIN US02155H2004 · United States · LEI 549300EOYCQ8SW3NVE64
- Fund shareholders
- 135
- Of which ETFs
- 26 109 other funds
- Value held
- ≈ 94.2M $ 94M $ · 215K €
- Share of capital
- 15.6 % of 194.5M shares on Aug 7, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 5,817 | 25.1K $ | 0.03 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Russell2000 ProShares Trust | 5,490 | 23.7K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares UltraPro Russell2000 ProShares Trust | 5,472 | 23.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| AZL DFA U.S. Core Equity Fund Allianz Variable Insurance Products Trust | 4,823 | 14.9K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 4,819 | 20.8K $ | 0.02 % | 0.00 % | as of Feb 28, 2026 ↗ |
| iShares Total U.S. Stock Market Index Fund BlackRock Funds | 4,063 | 10.6K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| SA U.S. Small Company Fund SA FUNDS INVESTMENT TRUST | 4,035 | 12.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| EQ/Franklin Small Cap Value Managed Volatility Portfolio EQ Advisors Trust | 3,972 | 12.2K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Russell 2000 High Income ETF ProShares Trust | 3,841 | 16.6K $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 3,790 | 11.7K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Morgan Stanley Pathway Small-Mid Cap Equity ETF MORGAN STANLEY PATHWAY FUNDS | 2,654 | 11.4K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| VIP Total Market Index Portfolio Variable Insurance Products Fund II | 2,587 | 8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| State Street Total Return V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 2,223 | 6.8K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Index Fund Penn Series Funds Inc | 2,100 | 6.5K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Total Stock Market Index Trust John Hancock Variable Insurance Trust | 1,758 | 5.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 1,655 | 7.1K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ULTRA SMALL CAP PROFUND ProFunds | 1,474 | 3.8K $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| TIAA Separate Account VA-1 - Stock Index Account TIAA Separate Account VA-1 | 1,340 | 4.1K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Nationwide Fundamental All Cap Equity Portfolio Nationwide Mutual Funds | 1,320 | 3.4K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Nuveen Life Stock Index Fund TIAA-CREF Life Funds | 827 | 2.5K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Avantis Responsible U.S. Equity ETF American Century ETF Trust | 763 | 3.3K $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000 2x Strategy Fund Rydex Dynamic Funds | 639 | 2K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Knights of Columbus U.S. ALL CAP INDEX FUND ADVISORS' INNER CIRCLE III | 560 | 1.5K $ | 0.00 % | 0.00 % | as of Apr 30, 2026 ↗ |
| State Street Balanced Index Fund STATE STREET INSTITUTIONAL INVESTMENT TRUST | 439 | 1.4K $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| PROFUND VP ULTRA SMALL CAP ProFunds | 436 | 1.3K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Goldman Sachs Absolute Return Tracker Fund GOLDMAN SACHS TRUST | 430 | 1.3K $ | 0.00 % | as of Mar 31, 2026 ↗ | |
| PROFUND VP SMALL CAP ProFunds | 330 | 1K $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Russell 2000 Fund Rydex Series Funds | 294 | 905.5 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| SMALL-CAP PROFUND ProFunds | 238 | 618.8 $ | 0.01 % | 0.00 % | as of Apr 30, 2026 ↗ |
| Russell 2000 1.5x Strategy Fund Rydex Series Funds | 176 | 542.1 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| Columbia Research Enhanced Small Cap ETF Columbia ETF Trust I | 103 | 317.2 $ | 0.01 % | 0.00 % | as of Mar 31, 2026 ↗ |
| ProShares Hedge Replication ETF ProShares Trust | 91 | 392.2 $ | 0.00 % | 0.00 % | as of Feb 28, 2026 ↗ |
| ProShares Russell 2000 Dynamic Buffer ETF ProShares Trust | 26 | 112.1 $ | 0.01 % | 0.00 % | as of Feb 28, 2026 ↗ |
| Russell 2000(R) 1.5x Strategy Fund Rydex Variable Trust | 21 | 64.7 $ | 0.00 % | 0.00 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 215K € | 0.26 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| GMO U.S. Small Cap Value Fund GMO TRUST | 0.44 % | as of Feb 28, 2026 ↗ |
| Invesco NASDAQ Future Gen 200 ETF Invesco Exchange-Traded Fund Trust II | 0.39 % | as of Feb 28, 2026 ↗ |
| Virtus Biotech Clinical Trials Etf ETFis Series Trust I | 0.36 % | as of Apr 30, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 0.29 % | as of Feb 28, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 0.26 % | as of Dec 31, 2025 ↗ |
| VANGUARD MARKET NEUTRAL FUND VANGUARD MONTGOMERY FUNDS | 0.25 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 0.18 % | as of Mar 31, 2026 ↗ |
| PROFUND VP BIOTECHNOLOGY ProFunds | 0.18 % | as of Mar 31, 2026 ↗ |
| Nuveen Life Small Cap Equity Fund TIAA-CREF Life Funds | 0.17 % | as of Mar 31, 2026 ↗ |
| Nuveen Quant Small Cap Equity Fund TIAA-CREF Funds | 0.13 % | as of Apr 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 134 | +2 | 30,438,773 | +33.6 % |
| 2026Q1 | 132 | +10 | 22,782,098 | +46.2 % |
| 2025Q4 | 122 | -4 | 15,584,326 | +6.3 % |
| 2025Q3 | 126 | -8 | 14,662,329 | +4.6 % |
| 2025Q2 | 134 | -2 | 14,018,430 | +3.6 % |
| 2025Q1 | 136 | 0 | 13,533,950 | -3.2 % |
| 2024Q4 | 136 | 0 | 13,986,484 | +0.8 % |
| 2024Q3 | 136 | +8 | 13,875,176 | -22.3 % |
| 2024Q2 | 128 | +12 | 17,855,094 | +62.8 % |
| 2024Q1 | 116 | +11 | 10,967,856 | -0.3 % |
| 2023Q4 | 105 | 11,004,833 |
Institutional managers
166 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 12,795,277 | 39.4M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 7,145,550 | 22M $ | as of Mar 31, 2026 |
| MARSHALL WACE, LLP | 4,017,901 | 12.4M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 3,258,191 | 10M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 3,107,096 | 9.6M $ | as of Mar 31, 2026 |
| Alyeska Investment Group, L.P. | 2,644,600 | 8.1M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 2,478,900 | 7.6M $ | as of Mar 31, 2026 |
| Nuveen, LLC | 2,334,601 | 7.2M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,350,649 | 4.2M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1,325,956 | 4.1M $ | as of Mar 31, 2026 |
| DIMENSIONAL FUND ADVISORS LP | 1,045,926 | 3.2M $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 996,721 | 3.1M $ | as of Mar 31, 2026 |
| UBS Group AG | 904,768 | 2.8M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 775,258 | 2.4M $ | as of Mar 31, 2026 |
| D. E. Shaw & Co., Inc. | 727,001 | 2.2M $ | as of Mar 31, 2026 |
| FMR LLC | 673,964 | 2.1M $ | as of Mar 31, 2026 |
| SCHRODER INVESTMENT MANAGEMENT GROUP | 667,837 | 1.9M $ | as of Mar 31, 2026 |
| TANG CAPITAL MANAGEMENT LLC | 666,022 | 2.1M $ | as of Mar 31, 2026 |
| Point72 Asset Management, L.P. | 665,289 | 2M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 570,203 | 1.8M $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 448,873 | 1.4M $ | as of Mar 31, 2026 |
| BNP PARIBAS FINANCIAL MARKETS | 435,078 | 1.3M $ | as of Mar 31, 2026 |
| Bank of New York Mellon Corp | 413,503 | 1.3M $ | as of Mar 31, 2026 |
| Beirne Wealth Consulting Services, LLC | 411,858 | 1.3M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 351,681 | 1.1M $ | as of Mar 31, 2026 |
Declared shareholders of Altimmune Inc
There are 6 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Deep Track Capital, LP and 3 others | 9.99 % | 19,417,221 | as of Apr 23, 2026 · SCHEDULE 13G |
| TCG Crossover GP II, LLC and 4 others | 9.80 % | 20,000,000 | as of Apr 24, 2026 · SCHEDULE 13G |
| VIKING GLOBAL INVESTORS LP and 9 others | 6.70 % | 13,400,000 | as of Apr 24, 2026 · SCHEDULE 13G |
| RA Capital Management, L.P. and 3 others | 6.50 % | 13,000,000 | as of Apr 24, 2026 · SCHEDULE 13G |
| STATE STREET CORPORATION | 5.50 % | 7,145,550 | as of Mar 31, 2026 · SCHEDULE 13G |
| TANG CAPITAL MANAGEMENT, LLC and 5 others | 0.30 % | 666,022 | as of Mar 31, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Fund shareholders of Altimmune Inc". https://titelia.com/en/stocks/altimmune-inc-US02155H2004